EUVIMEDEUVIMED entdecken
Crossref

AB019. Bridging the gap: enhancing drug allergy knowledge and management confidence in non-allergist physicians with ADAPT-2—a multinational, AI-assisted, educational initiative

Hugo W. F. Mak, Michaela Lucas, Jasmine T. Y. Lee, Rishabh Kulkarni, Sophia S. C. Chan, Philip H. Li

Journal of Public Health and Emergency · 2026-07 · 10 · AB019-AB019

DOI: 10.21037/jphe-26-ab019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Public Health and Emergency, 2026-07. Verfasst von Hugo W. F. Mak und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mislabeled drug allergy (DA) is a global public health challenge associated with emerging antimicrobial resistance, necessitating not only efforts from allergists but also multidisciplinary collaborations with non-allergist physicians. A randomized crossover trial, Advances in Drug Allergy & Penicillin Testing (ADAPT; NCT06399601), was first conducted in late 2023 and demonstrated promising outcomes in improving non-allergist physicians’ DA knowledge and confidence through an intensive educational programme. Following ADAPT’s success, we commenced a multinational phase in 2024—the ADAPT-2. This report aims to report the effectiveness of this initiative on improving participants’ DA knowledge and management confidence.

Methods

Non-allergist physicians were recruited from four localities, namely Australia, Hong Kong, mainland China, and Sri Lanka, and received a 1-day intensive training in DA. The training programme in mainland China was translated into Mandarin with artificial intelligence (AI) assistance. Participants’ DA knowledge, confidence, and practice were evaluated by structured surveys (scored on a 0–100 scale) before and after the course. Subgroup analysis was performed between physicians from advanced economies (AEs) and emerging economies (EEs).

Results

A total of 181 physicians [13 (7.2%) from Australia, 25 (13.8%) from Hong Kong, 98 (54.1%) from mainland China, and 45 (24.9%) from Sri Lanka] were included. At baseline, physicians’ knowledge and confidence level for DA were unsatisfactory (53.5±17.2 and 47.5±22.7, respectively). In particular, physicians from EEs (mainland China and Sri Lanka) showed significantly lower scores than those from AEs (Australia and Hong Kong) in DA knowledge (49.1±15.5 vs. 70.1±12.7, P

Zitieren

APA

Mak, H. W. F., Lucas, M., Lee, J. T. Y., Kulkarni, R., Chan, S. S. C., & Li, P. H. (2026). AB019. Bridging the gap: enhancing drug allergy knowledge and management confidence in non-allergist physicians with ADAPT-2—a multinational, AI-assisted, educational initiative. Journal of Public Health and Emergency, 10, AB019-AB019. https://doi.org/10.21037/jphe-26-ab019

Vancouver

Mak HWF, Lucas M, Lee JTY, Kulkarni R, Chan SSC, Li PH. AB019. Bridging the gap: enhancing drug allergy knowledge and management confidence in non-allergist physicians with ADAPT-2—a multinational, AI-assisted, educational initiative. Journal of Public Health and Emergency. 2026;10:AB019-AB019. doi:10.21037/jphe-26-ab019

BibTeX
@article{Mak2026,
  author = {Mak, Hugo W. F. and Lucas, Michaela and Lee, Jasmine T. Y. and Kulkarni, Rishabh and Chan, Sophia S. C. and Li, Philip H.},
  title = {AB019. Bridging the gap: enhancing drug allergy knowledge and management confidence in non-allergist physicians with ADAPT-2—a multinational, AI-assisted, educational initiative},
  journal = {Journal of Public Health and Emergency},
  year = {2026},
  volume = {10},
  pages = {AB019--AB019},
  doi = {10.21037/jphe-26-ab019}
}
Kostenlos starten →